Science 37 is an American clinical research company that specializes in decentralized clinical trials. In March 2024, the company was acquired by eMed, LLC.
History
Science 37 was founded in 2014
by Noah Craft and Belinda Tan, working out of LA BioMed at
Harbor-UCLA Medical Center.
Their team developed the Network Oriented Research Assistant platform, also known as the NORA platform, which includes video chat, digital self-photography, data collection, and electronic consent. Together, these features were used to conduct “site-less” trials.
The platform also aided researchers in finding and contacting potential participants, and scheduling trial participants for in-home activities like questionnaires, mobile nurse visits, and door-step study medicine delivery.
Science 37 received its initial round of funding in 2015, with a $6.5 million investment, co-led by
Lux Capital
Lux Capital is a venture capital firm based in New York City. It was founded in 2000, and focuses on investments in emerging technologies.
History
Lux Capital was founded in 2000 by Peter Hébert, Robert Paull and Josh Wolfe. In April 2011, for ...
and dRx Capital. In 2016 the company's second round of financing resulted in $31 million in funding, and a 2017 round of financing resulted in $29 million. In March 2019, Science 37 secured $35 million in Series D funding; and announced a leadership transition with David Coman coming in as CEO in November 2019.
In August 2020 Science 37 closed an oversubscribed Series D $40 million funding round led by Lux Capital, Redmile Group and
PPD, Inc. (other investors:
Novartis
Novartis AG is a Swiss multinational corporation, multinational pharmaceutical company, pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by re ...
,
Amgen
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical Corporation, company headquartered in Thousand Oaks, California. As one of the world's largest independent biotechnology companies, Amgen has a ...
, Sanofi Ventures,
GV, Glynn Capital, LifeSci Ventures and Mubadala Ventures). In May 2021, Science 37 announced that they are to become publicly listed via merger with LifeSci Acquisition II Corp.
Partnerships
In 2015 Science 37 began working with
Genentech
Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. It operates as an independent subsidiary of holding company Roche. Genentech Research and Early Development operates as an independent cent ...
in the recruitment of trial participants. In 2017 Science 37 then completed a site-less trial for
AOBiome Therapeutics. This was the first “interventional, randomized, placebo-controlled trial” to be completed virtually.
That year Science 37 also began planning site-less trials for
Sanofi
Sanofi S.A. is a French Multinational corporation, multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 200 ...
and
Otsuka Pharmaceutical
(), abbreviated OPC, is a pharmaceutical company headquartered in Tokyo, Osaka and Naruto, Tokushima, Naruto, Japan. The company was established August 10, 1964.
History
OPC's parent company Otsuka Holdings Co. Ltd. joined the Tokyo Stock Excha ...
.
In 2018 the company partnered with Novartis to plan several site-less clinical trials. Novartis also owns 10% of Science 37 from an early-stage investment in the company.
Science 37 was already in the process of conducting trials with Novartis in
acne
Acne ( ), also known as ''acne vulgaris'', is a long-term Cutaneous condition, skin condition that occurs when Keratinocyte, dead skin cells and Sebum, oil from the skin clog hair follicles. Typical features of the condition include comedo, ...
,
cluster headache
Cluster headache is a neurological disorder characterized by recurrent severe headaches on one side of the head, typically around the eye, eye(s). There is often accompanying eye watering, nasal congestion, or swelling around the eye on the aff ...
s, and
fatty liver disease
Fatty liver disease (FLD), also known as hepatic steatosis and steatotic liver disease (SLD), is a condition where excess fat builds up in the liver. Often there are no or few symptoms. Occasionally there may be tiredness or pain in the upper r ...
.
References
{{reflist
External links
Official website
Medical and health organizations based in California
2014 establishments in California
Companies formerly listed on the Nasdaq
2024 mergers and acquisitions